|
|||||||
|
For osteoporosis, bone trauma, menopause, inflammation, and periodontal disease
Three (3) tablets supply:
Vitamin C (as ascorbic acid)) 120 mg
Vitamin D (as cholecalciferol) 200 IU
Vitamin K (as phytonadione) 65 mcg
Thiamin (B1) (as mononitrate) 1.5 mg
Riboflavin (B2) 1.7 mg
Niacin (as niacinamide) 20 mg
Vitamin B6 (as pyridoxine HCI) 2 mg
Folate 400 mcg
Vitamin B12 (as resin bound cobalamin) 6 mcg
Biotin 300 mcg
Pantothenic Acid (as calcium pantothenate) 10 mg
Calcium (as calcium citrate) 500 mg
Magnesium (as magnesium oxide) 200 mg
Zinc (as zinc gluconate) 5 mg
Copper (as copper gluconate) 2 mg
Manganese (as manganese gluconate) 5 mg
Purified Chondroitin Sulfate 200 mg
Boron (as calcium borogluconate) 3 mg
Silicon (from Saccharum Officinarum extract) 100 mcg
Osteo Support Formula
90 tablets; 180 tablets
2 tablets three times daily with meals or as directed.
No Data Available
Independent research and additional information
Fox CH, Ramsoomair D, Mahoney MC, Carter C, Young B, Graham R. An investigation of hypomagnesemia among ambulatory urban African Americans. J Fam Pract. 1999 Aug;48( 8):636-9.Shamberger RJ. Calcium, magnesium, and other elements in the red blood cells and hair of normals and patients with premenstrual syndrome. Biol Trace Elem Res. 2003 Aug;94( 2):123-9
Iketani T, Kiriike N, Murray, Stein B, Nagao K, Nagata T, Minamikawa N, Shidao A, Fukuhara H. Effect of menatetrenone ( vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res. 2003 Mar 25;117( 3):259-69
McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004 May 13;350( 20):2042-9
Eisinger J, Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res. 1993 Sep;6( 3):247-9
Schiano A, Eisinger F, Detolle P, Laponche AM, Brisou B, Eisinger J. [Silicon, bone tissue and immunity] [Article in French] Rev Rhum Mal Osteoartic. 1979 Jul-Sep;46( 7-9):483-6
Schaafsma A, de Vries PJ, Saris WH. Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr. 2001 May;41( 4):225-49
Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993 Sep;6( 3):291-6
Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9( 2):61-9
Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002 Jun 19; 287( 23): 3127-9
Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity ( increased K( m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002 Apr;75( 4):616-58
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.
![]() |
Osteo-B-Plus w-D,K,Boron
IndicationsFor osteoporosis, bone trauma, menopause, inflammation, and periodontal disease IngredientsThree (3) tablets supply: Quantity
Dose2 tablets three times daily with meals or as directed. Potential side effects/SafetyNo Data Available |
---|